Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease

Annals of Allergy, Asthma and Immunology

Volumn 90, Issue 3, 2003, Pages 338-341

  Berges Gimeno, M Pilar ^a,b   Simon, Ronald A ^a,c   Stevenson, Donald D ^a,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PREDNISONE;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; MAXIMUM TOLERATED DOSE; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SYMPTOMATOLOGY;

EID: 0037347375     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61803-0     Document Type: Article

References (19)

1. Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177-180.
2. Stevenson D, Simon, RA. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Middleton E Jr, Ellis EF, Yunginger JW, et al, editors. Allergy: Principles and Practice. Vol 2. St. Louis, MO: Mosby, 1998:1225-1234.
3. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13.
4. Widal MF, Abrami P, Lermeyez J. Anaphylaxie et idiosyncrasie. Presse Med 1922;30:189-192.
5. Zeiss CR, Lockey RF. Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol 1976;57:440-448.
6. Pasargiklian M, Bianco S, Allegra L, et al. Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. Respiration 1977;34:78-91.
7. Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980;66:82-88.
8. Stevenson DD, Pleskow WW, Simon RA, et al. Aspirin-sensitive rhinosinusitis asthma: a double blind, cross-over study of treatment with aspirin. J Allergy Clin Immunol 1984;73: 500-507.
9. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization-treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 1990;85:59-65.
10. Stevenson DD, Hankammer MA, Mathison DA, et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996;98:751-758.
11. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health, 1997; Publication no. 97-4051:1.
12. Stevenson DD. Oral challenges to detect aspirin and sulfite sensifivity in asthma. N Engl Reg Allergy Proc 1988;9:135-142.
13. Stevenson DD. Anaphylactic and anaphylactoid reactions to aspirin and nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 2001;21:745-768.
14. Kowalski ML, Grzelewska-Rzymowska I, Szmidt M, Rozniecki J. Clinical efficacy of aspirin in "desensitised" aspirin-sensitive asthmatics. Eur J Respir Dis 1986;69:219-225.
15. Ferreri NR, Howland WC, Stevenson DD, Spiegelberg HL. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988;137:847-854.
16. Bosso JV, Schwartz LB, Stevenson DD. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol 1991;88:830-837.
17. 4 production following aspirin desensitization. J Allergy Clin Immunol 1995;96:148-156.
18. 4 in subjects with aspirin-induced asthma. Am Rev Respir Dis 1989;140:148-153.
19. 4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 1999;104:559-564.